Parametrica Management LTD Eli Lilly & CO Transaction History

Parametrica Management LTD

$83.5 Million
Q3 2024

A detailed history of Parametrica Management LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Parametrica Management LTD holds 1,800 shares of LLY stock, worth $1.34 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares

1,800

Previous 5,100 64.71%

Holding current value

$1.34 Million

Previous $4.62 Million 65.48%

% of portfolio

1.91%

Previous 6.11%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$772.14 - $960.02 $2.55 Million - $3.17 Million	-3,300 Reduced 64.71%	1,800 $1.59 Million
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $3.7 Million - $4.64 Million	5,100 New	5,100 $4.62 Million
Q4 2023 Feb 02, 2024	SELL	$525.19 - $619.13 $2.53 Million - $2.98 Million	-4,809 Reduced 80.24%	1,184 $690,000
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $774,635 - $1.07 Million	-1,782 Reduced 22.92%	5,993 $3.22 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $18,238 - $24,386	-52 Reduced 0.66%	7,775 $3.65 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $194,765 - $228,742	627 Added 8.71%	7,827 $2.69 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $734,098 - $855,371	2,283 Added 46.43%	7,200 $2.63 Million
Q3 2022 Nov 02, 2022	SELL	$296.48 - $337.87 $190,043 - $216,574	-641 Reduced 11.53%	4,917 $1.59 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $1.55 Million - $1.82 Million	5,558 New	5,558 $1.81 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $290,273 - $384,101	-2,225 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $325,339 - $376,314	2,225 New	2,225 $329,000
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $261,361 - $292,803	-2,468 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$85.86 - $107.31 $211,902 - $264,841	2,468 New	2,468 $265,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Parametrica Management LTD with notifications on news.

Account

Parametrica Management LTD Eli Lilly & CO Transaction History